214 related articles for article (PubMed ID: 20086105)
1. Long-term postmenopausal hormone therapy and endometrial cancer.
Razavi P; Pike MC; Horn-Ross PL; Templeman C; Bernstein L; Ursin G
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):475-83. PubMed ID: 20086105
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-progestin replacement therapy and endometrial cancer.
Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
[TBL] [Abstract][Full Text] [Related]
3. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
4. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
[TBL] [Abstract][Full Text] [Related]
5. Risk of endometrial cancer following estrogen replacement with and without progestins.
Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
[TBL] [Abstract][Full Text] [Related]
6. Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort.
Canchola AJ; Chang ET; Bernstein L; Largent JA; Reynolds P; Deapen D; Ursin G; Horn-Ross PL
Cancer Causes Control; 2010 Sep; 21(9):1407-16. PubMed ID: 20431936
[TBL] [Abstract][Full Text] [Related]
7. Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer.
Doherty JA; Cushing-Haugen KL; Saltzman BS; Voigt LF; Hill DA; Beresford SA; Chen C; Weiss NS
Am J Obstet Gynecol; 2007 Aug; 197(2):139.e1-7. PubMed ID: 17689625
[TBL] [Abstract][Full Text] [Related]
8. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.
Chubak J; Doherty JA; Cushing-Haugen KL; Voigt LF; Saltzman BS; Hill DA; Beresford SA; Weiss NS
Cancer Causes Control; 2007 Nov; 18(9):1001-7. PubMed ID: 17653829
[TBL] [Abstract][Full Text] [Related]
9. Variations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancer.
Razavi P; Lee E; Bernstein L; Van Den Berg D; Horn-Ross PL; Ursin G
Int J Cancer; 2012 Apr; 130(7):1629-38. PubMed ID: 21544810
[TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
[TBL] [Abstract][Full Text] [Related]
11. Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study.
Jaakkola S; Lyytinen HK; Dyba T; Ylikorkala O; Pukkala E
Int J Cancer; 2011 Apr; 128(7):1644-51. PubMed ID: 21280035
[TBL] [Abstract][Full Text] [Related]
12. Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer.
Phipps AI; Doherty JA; Voigt LF; Hill DA; Beresford SA; Rossing MA; Chen C; Weiss NS
Cancer Causes Control; 2011 Dec; 22(12):1639-46. PubMed ID: 21909949
[TBL] [Abstract][Full Text] [Related]
13. Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States).
Newcomb PA; Trentham-Dietz A
Cancer Causes Control; 2003 Mar; 14(2):195-201. PubMed ID: 12749724
[TBL] [Abstract][Full Text] [Related]
14. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
Pike MC; Ross RK
Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
[TBL] [Abstract][Full Text] [Related]
15. Estrogens, progestins, and risk of breast cancer.
Pike MC; Wu AH; Spicer DV; Lee S; Pearce CL
Ernst Schering Found Symp Proc; 2007; (1):127-50. PubMed ID: 18540571
[TBL] [Abstract][Full Text] [Related]
16. Menopausal hormone therapy and risk of epithelial ovarian cancer.
Rossing MA; Cushing-Haugen KL; Wicklund KG; Doherty JA; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2548-56. PubMed ID: 18086757
[TBL] [Abstract][Full Text] [Related]
17. Hormone therapy and risk of ovarian cancer in postmenopausal women: a systematic review and meta-analysis.
Shi LF; Wu Y; Li CY
Menopause; 2016 Apr; 23(4):417-24. PubMed ID: 26506499
[TBL] [Abstract][Full Text] [Related]
18. Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study.
Saxena T; Lee E; Henderson KD; Clarke CA; West D; Marshall SF; Deapen D; Bernstein L; Ursin G
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2366-78. PubMed ID: 20699377
[TBL] [Abstract][Full Text] [Related]
19. Exogenous Hormone Use and Endometrial Cancer in U.S. Black Women.
Sponholtz TR; Palmer JR; Rosenberg LA; Hatch EE; Adams-Campbell LL; Wise LA
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):558-565. PubMed ID: 29475971
[No Abstract] [Full Text] [Related]
20. Postmenopausal hormone replacement therapy use and risk of endometrial cancer in Japanese women.
Mizunuma H; Honjo H; Aso T; Urabe M; Ohta H; Kobayashi S; Sagara Y; Sanada M; Tanaka K; Dobashi K; Hayashi K; Ohama K
Climacteric; 2001 Dec; 4(4):293-8. PubMed ID: 11770185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
